Crestwood Advisors Group LLC Novartis Ag Transaction History
Crestwood Advisors Group LLC
- $5.16 Billion
- Q4 2024
A detailed history of Crestwood Advisors Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 2,309 shares of NVS stock, worth $243,437. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,309
Previous 2,104
9.74%
Holding current value
$243,437
Previous $242,000
7.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,468Shares Held
134MCall Options Held
1.4MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.29 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.16 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$863 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$724 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$588 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $227B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...